Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Torres

Showing results (381-390 of 794) with videos related to

Pageof 80
Sort By:
COPD|October 4, 2014
C-Reactive Protein at Discharge, Diabetes Mellitus and ≥ 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseErnesto Crisafulli, Antoni Torres, Arturo Huerta, et al.
International Journal of Antimicrobial Agents|December 10, 2023
The efficacy of telavancin in comparison with linezolid on endotracheal tube biofilm in pigs with methicillin-resistant Staphylococcus aureus pneumoniaKasra Kiarostami, Laia Fernández-Barat, Denise Battaglini, et al.
Pneumonia (Nathan Qld.)|March 25, 2026
Eosinopenia and prognosis in severe community-acquired pneumoniaCatia Cilloniz, Tatiana Castañeda, Antonio Campanella, et al.
Journal of Medical Economics|November 6, 2019
Economic analysis of ceftaroline fosamil for treating community-acquired pneumonia in SpainAntoni Torres, Matteo Bassetti, Tobias Welte, et al.
The European Respiratory Journal|January 24, 2015
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosisAntoni Torres, Catia Cillóniz, Miquel Ferrer, et al.
Intensive Care Medicine|February 10, 2012
Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failureAndres Carrillo, Gumersindo Gonzalez-Diaz, Miquel Ferrer, et al.
The Journal of Infection|September 26, 2022
Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumoniaLeyre Serrano, Luis Alberto Ruiz, Silvia Pérez, et al.
Chest|January 11, 2026
Pseudomonas aeruginosa in patients with Nosocomial Respiratory Infections: A secondary analysis of the European Network for ICU-Related Respiratory Infections (ENIRRIs)Cristian C Serrano-Mayorga, Juan Olivella-Gomez, Natalia Sanabria-Herrera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2003
Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumoniaJosé A Martínez, Juan P Horcajada, Manuel Almela, et al.
Respirology (Carlton, Vic.)|June 10, 2014
Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical studyMiquel Ferrer, Antoni Torres, Raquel Martínez, et al.
Pageof 80

Showing results (381-390 of 794) with videos related to

Sort By:
Pageof 80
COPD|October 4, 2014
C-Reactive Protein at Discharge, Diabetes Mellitus and ≥ 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseErnesto Crisafulli, Antoni Torres, Arturo Huerta, et al.
International Journal of Antimicrobial Agents|December 10, 2023
The efficacy of telavancin in comparison with linezolid on endotracheal tube biofilm in pigs with methicillin-resistant Staphylococcus aureus pneumoniaKasra Kiarostami, Laia Fernández-Barat, Denise Battaglini, et al.
Pneumonia (Nathan Qld.)|March 25, 2026
Eosinopenia and prognosis in severe community-acquired pneumoniaCatia Cilloniz, Tatiana Castañeda, Antonio Campanella, et al.
Journal of Medical Economics|November 6, 2019
Economic analysis of ceftaroline fosamil for treating community-acquired pneumonia in SpainAntoni Torres, Matteo Bassetti, Tobias Welte, et al.
The European Respiratory Journal|January 24, 2015
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosisAntoni Torres, Catia Cillóniz, Miquel Ferrer, et al.
Intensive Care Medicine|February 10, 2012
Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failureAndres Carrillo, Gumersindo Gonzalez-Diaz, Miquel Ferrer, et al.
The Journal of Infection|September 26, 2022
Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumoniaLeyre Serrano, Luis Alberto Ruiz, Silvia Pérez, et al.
Chest|January 11, 2026
Pseudomonas aeruginosa in patients with Nosocomial Respiratory Infections: A secondary analysis of the European Network for ICU-Related Respiratory Infections (ENIRRIs)Cristian C Serrano-Mayorga, Juan Olivella-Gomez, Natalia Sanabria-Herrera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2003
Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumoniaJosé A Martínez, Juan P Horcajada, Manuel Almela, et al.
Respirology (Carlton, Vic.)|June 10, 2014
Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical studyMiquel Ferrer, Antoni Torres, Raquel Martínez, et al.
Pageof 80